ReviewDiscover nano2025
Curcumin-based biocompatible nanocarriers: a contemporary perspective in functional foods and biomedical applications.
Review in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Epigenetic regulators polyphenols in neurodegenerative diseases: a promising intervention strategy.Annals of medicine · 2026Review
- Curcumin's Protective Effects Against HMolecules (Basel, Switzerland) · 2026Review
- Design of Ion-Pairing Azithromycin liposome for Local Pulmonary Delivery with Prolonged Lung Retention.AAPS PharmSciTech · 2026Article
- Nanocarriers engineering for efficient NSUN2 silencing and immune responsive therapy in metastatic colorectal cancer.Materials today. Bio · 2026Article
- Therapeutic potential of allicin against viral infections: Mechanisms and safety profile (Review).Experimental and therapeutic medicine · 2026Review
- A QbD-optimized magnetic MOF-chitosan nanocarrier for targeted curcumin delivery and synergistic antimicrobial activity.RSC advances · 2026Article
- Natural Products and Antimicrobial Nanoparticles Against Methicillin-ResistantPharmaceutics · 2026Review
- Curcumin-Selenium Nanocomposites Integrated into Sol-Gel Siloxane Matrices for Antimicrobial and Delivery Applications.Gels (Basel, Switzerland) · 2026Article
- Curcumin-Based Nanoformulations for Oral Health: Mechanistic Insights, Antimicrobial Efficacy, and Future Clinical Perspectives.Biomedicines · 2026Review
- Curcumin as theranostics: imaging-guided therapeutics in oncology and neurodegenerative diseases.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Curcumin, a naturally occurring polyphenolic compound derived from Curcuma longa, has garnered substantial interest for its extensive pharmacological properties, including antioxidant, anti-inflammatory, antimicrobial, and anticancer effects. However, its clinical and nutritional applications are hindered by significant physicochemical challenges, including poor water solubility, rapid metabolic degradation, and low systemic bioavailability. Recent advances in nanotechnology have opened new pathways for enhancing curcumin's therapeutic potential through the development of biocompatible nanocarrier systems. These nanoformulations, including liposomes, polymeric nanoparticles, solid lipid nanoparticles, nanoemulsions, dendrimers, and cyclodextrin complexes, offer improved solubility, protection from enzymatic and environmental degradation, targeted delivery, and controlled release profiles. This review critically explores the evolution and design of curcumin-based nanocarriers with applications spanning functional food systems and biomedical therapeutics. It provides a comprehensive synthesis of the formulation strategies. The integration of nano-curcumin into functional foods has also shown promising results in improvements of sensory acceptability across dairy, beverage, bakery, and nutraceutical products. In therapeutic applications, curcumin-loaded nanocarriers demonstrate superior efficacy in cancer therapy, neurodegenerative disorders, hepatoprotection, the management of metabolic syndrome, and wound healing, owing to their targeted delivery and controlled release mechanisms. The novelty of this review lies in its comprehensive and critical synthesis that brings together advances in nanocarrier design and application across both biomedical and functional food domains. By integrating evidence from pharmacology, materials science, and food technology, it highlights how nanocarrier strategies address the multifaceted limitations of native curcumin and identifies common principles guiding their translation. Future perspectives include the development of innovative and stimuli-responsive systems, the need for global standardization, expansion of clinical trials, and integration into personalized nutrition platforms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.